Alaunos Therapeutics Inc

NASDAQ:TCRT   4:00:00 PM EDT
0.65
-0.01 (-1.73%)
: $0.66 +0.01 (+0.86%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Alaunos Therapeutics Inc Stock, NASDAQ:TCRT

8030 El Rio Street, 1 First Avenue, Houston, Texas 77054
United States of America
Phone: +1.346.355.4099
Number of Employees: 41

Description

Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. Its pipeline includes Library TCR-T cell and mblL-15 TCR-T cell Therapy. The company was founded in 2003 and is headquartered in Houston, TX.